Phloridzin (Dihydrochalcone Glycoside · SGLT Inhibition · Blood Glucose)

Compound	Phloridzin
Chemical class	Polyphenol — Dihydrochalcone Glycoside (Phloretin-2′-O-glucoside)
CAS	60-81-1
Primary source	Malus domestica (apple root bark, leaves)
Key applications	SGLT inhibition, blood glucose, conceptual basis for SGLT2 inhibitor drugs
Claim strength	Moderate
Typical form	Apple polyphenol extract; phloridzin isolate
Buy from Herbuno	Green Apple Extract Powder → Bromelain 3000 GDU/g Powder (Pineapple Extract) | Standardized Ananas comosus →

Name origin: From Greek phloos (bark) + rhiza (root) — reflecting its original isolation from apple root bark. Phloridzin is the 2′-O-glucoside of phloretin, making it the dominant glycoside form in apple tree tissues. Traditional use: Apple root bark decoctions have been used in European folk medicine as anti-fever and anti-diabetic preparations — effects now understood to relate to phloridzin’s sodium-glucose co-transporter inhibition. Research trajectory: Phloridzin is historically significant as the compound that established the concept of renal glucose reabsorption, leading directly to the pharmaceutical development of SGLT2 inhibitors (gliflozins — a multi-billion dollar drug class). It has moderate clinical evidence for blood glucose lowering and is of active research interest for SGLT1/SGLT2-mediated applications in diabetes and obesity. Commercial source: Commercially available via apple polyphenol extract and as an isolated dihydrochalcone glycoside from apple tree bark. See sourcing options below.

---

Evidence for Phloridzin Applications

SGLT1/SGLT2 inhibition and blood glucose reduction: Phloridzin inhibits SGLT1 (intestinal glucose absorption) and SGLT2 (renal glucose reabsorption), reducing post-prandial blood glucose and increasing urinary glucose excretion. This dual SGLT inhibition mechanism directly established the pharmacological rationale for the SGLT2 inhibitor drug class. Animal studies confirm significant blood glucose reduction. Small human pilot data support glucose-lowering effects at gram-level doses. Claim strength: Moderate (established mechanism; limited human supplement trials).

Anti-inflammatory and antioxidant: Phloridzin demonstrates NF-κB inhibition and antioxidant activity comparable to phloretin aglycone in cell models. The glucose moiety reduces lipophilicity relative to phloretin, potentially altering tissue distribution and bioavailability. Claim strength: Moderate.

Weight management and metabolic: Urinary glucose excretion induced by SGLT inhibition represents a caloric loss pathway relevant to weight management. In animal models of obesity, phloridzin reduces body weight alongside blood glucose. Human weight management data at supplement doses are not established. Claim strength: Emerging.

---

Dosage & Formulator Specification

Animal pharmacology studies use 50–200 mg/kg phloridzin for significant SGLT inhibition. Human equivalent doses are high (3.5–14 g/day for a 70 kg adult) — well above practical supplement delivery. Pharmaceutical SGLT2 inhibitors achieve equivalent outcomes at milligram doses due to superior selectivity and bioavailability. For supplement contexts, phloridzin is best positioned as a contributing active within a broad-spectrum apple polyphenol extract rather than as a primary glucose-lowering ingredient.

Apple polyphenol extract at 200–500 mg/day delivers phloridzin alongside phloretin, chlorogenic acids, and catechins, providing multi-mechanism metabolic support. For phloridzin-specific standardisation, request HPLC quantification of phloridzin alongside total dihydrochalcone content in the extract specification.

Phloridzin has better aqueous solubility than phloretin aglycone (due to glucoside moiety); standard capsule and tablet formats are appropriate. Gut hydrolysis by lactase-phloridzin hydrolase (LPH) in the small intestine releases phloretin, which is then absorbed — meaning phloridzin serves partly as a phloretin prodrug in vivo.

---

Frequently Asked Questions — Phloridzin

Is phloridzin the same as pharmaceutical SGLT2 inhibitors?
Phloridzin is the natural SGLT inhibitor that established the SGLT concept, but pharmaceutical SGLT2 inhibitors (dapagliflozin, empagliflozin, canagliflozin) are synthetic analogues designed for SGLT2 selectivity over SGLT1. Phloridzin inhibits both SGLT1 and SGLT2 non-selectively, which causes GI side effects (diarrhoea from SGLT1 inhibition in the gut) that the selective drugs avoid. This limits phloridzin’s usefulness as a pharmaceutical but does not prevent its use in supplement contexts at lower doses.

Why can’t phloridzin be used as a natural alternative to SGLT2 inhibitor drugs?
Three practical barriers: dose (effective human doses are grams, not milligrams); selectivity (non-selective SGLT1 + SGLT2 inhibition causes GI adverse effects at effective doses); and regulatory pathway (pharmaceutical claims require drug approval). Phloridzin is best positioned as a metabolic support ingredient at sub-pharmacological supplement doses, not as a natural drug substitute.

Does phloridzin convert to phloretin in the body?
Yes. Small intestinal lactase-phloridzin hydrolase (LPH) and gut microbial glucosidases hydrolyse phloridzin to phloretin and glucose. Phloretin is then absorbed. The two compounds have overlapping but distinct pharmacological profiles: phloridzin has SGLT activity in the gut lumen before hydrolysis; phloretin has GLUT activity intracellularly after absorption.

Is phloridzin relevant for skincare applications?
Phloridzin has antioxidant activity and some evidence for skin brightening (tyrosinase inhibition) comparable to phloretin. However, its better aqueous solubility makes it somewhat more appropriate for aqueous cosmetic formats than phloretin. The aglycone phloretin is more commonly used in premium cosmeceuticals due to its better membrane permeability.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery